-
ACXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Acurx Pharmaceuticals (ACXP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.76 mm | 5.76 mm | 5.76 mm | 5.76 mm | 5.76 mm | 5.76 mm |
Cash burn (monthly) | 199.43 k | 107.48 k | 940.53 k | 1.37 mm | 729.94 k | 1.03 mm |
Cash used (since last report) | 1.02 mm | 548.20 k | 4.80 mm | 6.99 mm | 3.72 mm | 5.24 mm |
Cash remaining | 4.75 mm | 5.21 mm | 965.43 k | -1.22 mm | 2.04 mm | 521.51 k |
Runway (months of cash) | 23.8 | 48.5 | 1.0 | -0.9 | 2.8 | 0.5 |
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 1 |
Closed positions | 11 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 2.15 bn |
Total shares | 1.15 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 529.35 k | $1.01 bn |
Prospect Financial Services | 295.08 k | $560.64 mm |
Geode Capital Management | 146.50 k | $278.38 mm |
LPL Financial | 44.78 k | $85.08 mm |
BlackRock | 28.54 k | $54.22 mm |
NTRS Northern Trust | 27.29 k | $51.84 mm |
NBC Securities | 19.00 k | $36.00 k |
TD Waterhouse Canada | 18.66 k | $35.63 mm |
Advisor | 14.21 k | $27.00 mm |
Patriot Financial Group Insurance Agency | 10.39 k | $19.73 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | Robert J Deluccia | Stock Option Common Stock | Grant | Acquire A | No | No | 0.7982 | 250,000 | 199.55 k | 250,000 |
5 Feb 25 | David P Luci | Stock Option Common Stock | Grant | Acquire A | No | No | 0.7982 | 250,000 | 199.55 k | 250,000 |
5 Feb 25 | Robert G. Shawah | Stock Option Common Stock | Grant | Acquire A | No | No | 0.7982 | 145,500 | 116.14 k | 145,500 |
6 Jan 25 | Scodari Joseph C | Common Stock | Buy | Acquire P | No | No | 1.015 | 24,631 | 25.00 k | 27,708 |
6 Jan 25 | Scodari Joseph C | Warrants for Common Stock Common Stock | Buy | Acquire P | No | No | 0.9 | 24,631 | 22.17 k | 24,631 |
6 Jan 25 | Robert J Deluccia | Common Stock | Buy | Acquire P | No | No | 1.015 | 49,261 | 50.00 k | 1,010,196 |
6 Jan 25 | Robert J Deluccia | Warrants for Common Stock Common Stock | Buy | Acquire P | No | No | 0.9 | 49,261 | 44.33 k | 49,261 |